Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial.

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated chronic illnesses including Long COVID, today announced two major milestones ...

There are a variety of therapies available compared to early in the pandemic. It's hard to imagine a time when treatments weren't available for COVID-19. Yet this was the case when the World Health ...

Severe maternal disease and preterm birth due to COVID-19 infection are less prevalent when immunization occurs before or during pregnancy, demonstrating the clinical benefit of vaccination in ...

Retrospective data from Southern Italy show a marked rise in pediatric septic head and neck infections, with greater severity ...

Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...

Yesterday, in introducing drastic cuts to the nation’s childhood immunization schedule, the Centers for Disease Control and Prevention (CDC) said “shared clinical decision-making” would be used for ...